Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.
Ritchie Torres filed legislation this week aimed at improving the HHS' response to mpox and other health emergencies.
The global Vaccine market has experienced a period of significant transformation, driven by a junction of factors. Valued at ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by ...